James Daniels, MD
Otology & Neurotology · Dallas, TXNPI 1427064088
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by Medtronic at 46.2% of the total. Reporting peaked in 2023 at $3,227 and has fallen 82.7% since, to $557 in 2025.
Across 36 payments — averaging $193.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$3K
- Boston Scientific$751
Across 47 payments — averaging $3526.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$119K
- Boston Scientific$32K
- Abbott$15K
What the payments were for
- Consulting fees$3,27547%
- Travel & lodging$2,78840%
- Food & beverage$89313%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 9 | $3,216 |
| Abbott | 20 | $2,989 |
| Boston Scientific | 7 | $751 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$2,409
- GENERAL - THERAPIES$469
- Arctic Front$176
- PulseSelect$119
How this compares
$6,957 in reported general payments places this provider in the 85th percentile of 33 otology & neurotology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 199 | $251,935 |
| XareltoRivaroxaban | 52 | $57,174 |
| Dofetilide | 61 | $17,609 |
| Propafenone Hcl ErPropafenone Hcl | 15 | $2,710 |
| Metoprolol Succinate | 115 | $1,869 |
| Flecainide Acetate | 20 | $908 |
| Amiodarone Hcl | 60 | $796 |
| Propafenone Hcl | 20 | $791 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $500 |
| Metoprolol Tartrate | 27 | $322 |
| Carvedilol | 31 | $249 |
| Warfarin Sodium | 24 | $248 |
| Pantoprazole Sodium | 17 | $188 |
| SotalolSotalol Hcl | 13 | $154 |
| Diltiazem 24hr ErDiltiazem Hcl | 11 | $134 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Dallas
- Brandon IsaacsonDallas$98K
- Joe KutzDallas$95K
- Joshua PageDallas$2K
- Brian RodgersDallas$2K
- Daniel KilleenDallas$959
- Hitomi SakanoDallas$113
- Chester StrunkWebster$8K
- Robert OwensPlano$7K
- Vivian KaulHouston$6K
- Mark NicholsHouston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.